FierceBiotech 29. Mai 2026 Agios’ next-gen PK drug fails blood cancer study but sickle cell disease ambitions remain undimmed
Thermo Fisher 29. Mai 2026 Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo Finance
FDA News Releases 29. Mai 2026 FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
Agilent 29. Mai 2026 Agilent Technologies (A) Margin Gains Reinforce Bullish Recurring Revenue Narrative After Q2 2026 Results - simplywall.st
FierceBiotech 29. Mai 2026 ASCO: BMS’ CELMoD drug doubles PFS in ‘incredibly exciting’ ph. 3 myeloma study
FierceBiotech 29. Mai 2026 ASCO: Lilly debuts ‘strong’ bladder cancer data for potential Padcev challenger
FierceBiotech 29. Mai 2026 Gilead scraps lead arthritis drug from $405M MiroBio buyout in latest blow to BTLA agonist field